23 December 2020
Davis Polk advised OrbusNeich Medical Company Limited in connection with its entry into an agreement with P+F Products & Features for the exclusive distribution and manufacturing of a range of innovative minimally invasive heart valve products in the Asia Pacific region, including China, Japan, Taiwan, South Korea, Hong Kong, Singapore, Malaysia, Australia and New Zealand.
OrbusNeich is headquartered in Hong Kong and is a global pioneer in the provision of life-changing vascular solutions and offers an extensive portfolio of products that set industry benchmarks in vascular intervention. Headquartered in Vienna, Austria, P+F Products & Features is striving to become the “standard of comparison” in the development of state-of-the-art innovative technologies in the field of cardiology products.
The Davis Polk corporate team included partner James C. Lin, counsel Sam Kelso and associate Tracy Wu. Partner Pritesh P. Shah and associate Christopher C. Woller provided intellectual property advice. Counsel Nicholas Spearing and associate Léonore De Mullewie provided competition law advice. Members of the Davis Polk team are based in the Hong Kong, New York and London offices.
